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Abstract
Skin is the largest human organ system, and its protective function is critical 
to survival. The epithelial, dermal, and subcutaneous compartments are hetero-
geneous mixtures of cell types, yet they all display age-related skin dysfunction 
through the accumulation of an altered phenotypic cellular state called senescence. 
Cellular senescence is triggered by complex and dynamic genetic and epigenetic 
processes. A senescence steady state is achieved in different cell types under vari-
ous and overlapping conditions of chronological age, toxic injury, oxidative stress, 
replicative exhaustion, DNA damage, metabolic dysfunction, and chromosomal 
structural changes. These inputs lead to outputs of cell-cycle withdrawal and 
the appearance of a senescence-associated secretory phenotype, both of which 
accumulate as tissue pathology observed clinically in aged skin. This review details 
the influence of genetic and epigenetic factors that converge on normal cutaneous 
cellular processes to create the senescent state, thereby dictating the response of the 
skin to the forces of both intrinsic and extrinsic aging. From this work, it is clear 
that no single biomarker or process leads to senescence, but that it is a convergence 
of factors resulting in an overt aging phenotype.
Keywords: skin, DNA damage, telomeres, epigenetics, immunosenescence, 
inflammaging
1. Introduction
A consensus agreement on the definition of cellular senescence may be stated as 
a viable but non-proliferative condition distinct from the G0 quiescent phase of the 
cell cycle and postmitotic terminal differentiation [1, 2]. While aged living organ-
isms accumulate senescent cells, aging and senescence are not synonymous terms—
the cellular and molecular pathways that eventuate in the senescent state can be 
activated by diverse mechanisms, not necessarily chronologic aging nor the limit of 
replicative cell division. It was the latter phenomenon, in fact, that led early inves-
tigators to the original concept of cellular senescence as an in vitro observation; that 
replicating fetal “skin tissue cells” stop dividing at a certain passage number, the 
so-called “Hayflick Limit” [3]. This review focuses on our current understanding of 
how cellular senescence occurs in the skin, its irreversible (and possibly reversible) 
characteristics, description of known trigger points involving genetic and epigen-
etic factors and their clinical implications in health and disease.
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Cellular senescence is characterized by cell cycle arrest [4], the expression of 
senescence associated secretory phenotype (SASP) [5, 6], damage to DNA [7–9], 
deregulated metabolic profile [2, 10], changes to the epigenome [11] and transcrip-
tome [12], resistance to apoptosis [13, 14], and altered immune surveillance [15, 
16]. It can be triggered by multiple factors [2], the mechanisms of which appear 
to categorize the ‘type’ of senescence into two main groups; so-called replicative 
senescence (RS) due to shortened telomeric DNA resulting from excessive cell 
division cycles [17–20]; and a state generally termed ‘premature senescence’ (PS), 
in which both oncogene-induced senescence (OIS), triggered by activation of 
oncogenes such as ras [21], and several other ‘molecular stresses’ [4] also eventuates 
in the senescent phenotype.
There are a variety of biomarkers for cellular senescence but not all senescent 
cells express the same biomarkers due to these differential molecular induction 
pathways. Several senescent biomarkers have been identified in the skin [22]; how-
ever, it is currently unclear how the multitude of cell types that comprise this tissue 
respond to senescence-inducing triggers and how this correlates with skin aging, 
other than the fact that senescent cells accumulate in all skin compartments with 
age, just like other organ systems. What is becoming clear, however, is that cellular 
senescence plays critical roles in the pathobiology of skin aging and disease [23].
2. Aging of the skin
Both intrinsic (time, genetic and hormonal) and extrinsic (environmental) 
factors contribute to skin aging. Old skin not only appears clinically different from 
young skin but has altered physiology due to a combination of molecular, cellular, 
and biochemical processes, and tracing the pathogenic origin of the ‘skin aging phe-
notype’ remains a work in progress. From a clinical perspective however, the skin of 
most people older than 6–7 decades of life, particularly in photo-exposed areas, is 
thinner, looser, less tethered to underlying tissue, more wrinkled, more translucent 
with more visible capillary vessels, more discolored, drier, and less padded by the 
subcutaneous layer [24, 25]. Scalp skin also ages, commonly observed as pigment 
loss (graying), and most people experience hair loss as another inevitable esthetic 
problem.
Anatomically, the structure of human integument tissue we call ‘skin’ is com-
posed of ectodermal-derived epithelial cells layered as stratified squamous epithe-
lium on top of mesenchymal-derived dermis separated by a specialized basement 
membrane zone (BMZ) called the dermal-epidermal junction (DEJ). Directly 
below the dermis is the fatty hypodermis (or subcutaneous layer) separating fascia 
and muscle from the skin. Epithelial-mesenchymal interactions that occur dur-
ing embryogenesis (and wound repair) contribute to the formation of glandular 
structures buried within these compartments (called adnexa) which are comprised 
of eccrine, apocrine, sebaceous and hair follicle structures. Peripheral nerves and 
blood vessels traverse the subcutaneous and dermal layers and together with all 
other structures of the integument, serve the functions of barrier protection, reten-
tion of heat and water, sensation, contractility, and lubrication [26].
This multi-compartmental system is the largest organ of the body and is 
composed of about 20 different cell types responsible for skin function and its 
stratification [27], all of which also change with age to contribute to the overall ‘skin 
aging phenotype’. At the microscopic level, skin tissues of older individuals exhibit 
common characteristics regardless of whether sun protected or chronically exposed 
to ultraviolet (UV) light [28]. The most obvious and well documented structural 
changes include epidermal thinning, loss of rete ridges and flattening of dermal 
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papillae [29, 30], keratinocyte and melanocyte architectural changes [31, 32],  
BMZ/DEJ alterations [33], less dense and altered reticular dermal collagen structure 
[34], accumulation of altered elastin and elastic fiber structural abnormalities [35], 
altered shape and loss of papillary dermal capillary loops [36–38], and size and 
structural alterations in glandular structures of the eccrine, apocrine and sebaceous 
units [39]. Concomitant with morphologic changes observed in aged skin, senescent 
cell populations increase in all skin compartments.
2.1 Effects of aging on epidermal structure and function
The epidermis, consisting of 5 different layers of keratinocytes, continuously 
renews itself on an approximate 27-day cycle by a differentiation program involv-
ing basal cells which are maintained and replenished by stem cells residing in the 
bulge region of the hair follicle and the interfollicular epidermis [40]. Of particular 
importance to aging of the epidermal compartment is the general concept that the 
cellular microenvironment (or niche) of stem cell populations plays a critical role 
in homeostatic resupply of transient amplifying basal cells [41]. The epidermis 
maintains a dynamic equilibrium by proliferating in the basal layer that is attached 
to the DEJ, then cell division ceases and basal keratinocytes undergo terminal dif-
ferentiation while spatially migrating towards the top of the epidermis. During this 
transition, keratinocytes acquire specialized cytoskeletal components and create 
an intercellular diffusion barrier, eventually forming the outermost epidermal 
layer called the stratum corneum (SC). The SC is a specialized acidic, hydrophobic, 
protein-lipid-carbohydrate flexible ‘shell’ resistant to wear and tear, water loss, and 
invasion of microbes [42]. The “barrier function” of the skin is derived from the SC.
The epidermal compartment appears to deal with the ravages of extrinsic 
aging in a fundamentally different way than the dermal compartment because 
terminally differentiated (cell cycle arrested) keratinocytes are continuously 
shed, thus removing accumulated DNA and other macromolecular damage that 
otherwise trigger the senescent phenotype. But since the epidermis is continuously 
replenished by stem cells arising from the interfollicular niche, its alteration can 
affect epidermal biology in profound ways. In fact, epidermal stem cell niche can be 
affected during aging by both basal keratinocytes [43] and dermal fibroblasts [44]. 
Niche microenvironments can be altered by intrinsic and extrinsic aging at cell-cell, 
cell-matrix and paracrine signaling levels, leading to stem cell depletion and the 
‘atrophic epidermal phenotype’ observed in intrinsic aged skin [45].
Many other cell types localize to the epidermis, including pigment-producing 
melanocytes found in the basal layer that protect against UV radiation. Pigment is 
synthesized within the melanocyte but transferred to neighboring basal keratino-
cytes (and specialized hair follicle-associated keratinocytes) via a complex melano-
somal exo/phagocytosis mechanism localizing at the dendritic tips of melanocytes 
which interdigitate with up to 20 keratinocytes [46]. Melanocyte dysfunction asso-
ciated with extrinsic aging (mostly photoaging) manifests clinically as abnormally 
dispersed and/or diminished melanin pigment (i.e., dyschromia, lentigines, and in 
the scalp, canities). Senescence of the melanocyte has been observed both in vitro 
and in vivo and the molecular pathways involved identified [47]. In fact, based on 
biomarker (e.g., P16) expression, senescent melanocytes appear to represent most 
senescent cells in aged epidermis [48] and their contributions to development of the 
epidermal atrophic phenotype via autocrine and paracrine (i.e., SASP) mechanisms 
have been identified [49].
The epidermal immune system is a network of resident antigen-presenting 
dendritic Langerhans cells (LC) thought to function as immune sentinels [50] 
together with trafficking lymphoid immune cells including resident memory T cells 
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as CD8+ and CD4+ cells [51]. Of interest, a specialized CD4 + T cell (Treg) residing 
near the hair follicle bulge areas (located in the dermis) has been shown to play a 
role in hair growth cycling [52]. Skin aging is associated with variable deterioration 
of both adaptive and innate immune function, generally referred to as cutaneous 
‘immunosenescence’. This term has become controversial in the literature [16] 
because immune cell senescence is, in part, a physiologic adaptive response to sur-
vival and fitness of the organism. Its use to describe altered skin immune responses 
with age appears appropriate in the context of inflammaging [53], since the concept 
of immunosenescence encompasses both systemic chronic, low-grade inflamma-
tion [i.e., elevated serum levels of interleukins IL-6 and IL-8 and increased tumor 
necrosis factor alpha (TNF-α), etc.] and the presence of dysfunctional immune 
responses in various skin compartments apparently related to both tissue level RS 
and PS. Currently unknown, however, is whether cutaneous inflammaging is a 
cause or an effect of dysfunctional innate immune responses observed in the elderly 
and whether cellular senescence is responsible.
Examples of cutaneous aged-related immune dysfunction include reported 
reductions in the number and functionality of LC in aged skin and this correlates 
with both age related defective epidermal barrier function and inflammaging 
[54]. Likewise, defective physiologic immune clearance of senescent cells that 
contribute to aged skin pathologies have been demonstrated in dermal fibroblasts 
by the observation that these cells express a nonclassical major histocompatibility 
antigen (HLA-E). Its increased expression appears to block activation of natural 
killer (NK) cells and CD8+ cells responsible for clearing damaged cells, suggesting 
that evasion of dermal immunosurveillance leads to persistence of senescent dermal 
fibroblasts [55].
Aging is a clinical comorbidity in many skin diseases pathogenically linked to 
defective cutaneous innate and adaptive immune responses [53]. The incidence and 
prevalence of autoimmune blistering disorders such as bullous pemphigoid (BP), 
pemphigus vulgaris, and epidermolysis bullosa acquisita are all increased in older 
populations, BP being the most common example [56]. Likewise, aging is a comor-
bidity in the development of skin cancers, and the loss of immunosurveillance due 
to dysfunctional LCs is thought to contribute to progression of both non-melanoma 
skin cancer (NMSC) [57] and melanoma [58].
Another unique cell type scattered along the DEJ, considered part of the epider-
mal compartment, and possessing mixed neuronal, endocrine, and immunologic 
functions (as well as embryonic origin) is the Merkel cell (MC) [59]. Its involve-
ment in the skin’s somatosensory system is key to the sense of fine touch discrimina-
tion, which is decreased in the elderly [60]. In glabrous skin MC form complexes 
with intraepidermal sensory neurites found at the DEJ termed ‘touch domes’ or 
Merkel’s discs. Digital skin of aged humans contains less of these complexes, lower 
density of MC and decreased expression of the stretch-activated ion-channel com-
ponent Piezo2 [61]. Occurring mainly in aged humans, a rare but very aggressive 
skin cancer, Merkel cell carcinoma (MCC) has attracted recent attention due to its 
mysterious etiopathogenesis. 80% of MCC is associated with integration of a newly 
identified polyoma virus (MCPyV) [62], whereas 20% appear linked to accumula-
tion of UV light-induced somatic mutations [63]. As detailed in the next section on 
epigenetics, it is of interest that the majority of MCC display expected chronologic 
age but DNA methylation patterns of epigenetically youthful cells [64].
2.2 Aging and the dermis
The dermal compartment is divided into superficial, reticular, and deep 
dermis with unique cellular, vascular, extracellular matrix (ECM), and adnexal 
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components that define each space. Much of the ‘business-end’ of the dermis is 
localized to the superficial dermal compartment and the DEJ is central to its struc-
ture and functionality. It is considered part of both the epidermis and the superfi-
cial dermis because cellular components of each layer contribute to its synthesis, 
maintenance, and renewal. Serving as an adhesive scaffolding for basal keratino-
cytes, a shear-resistant Velcro-like surface securing the dermis to the epidermis, a 
complex paracrine factor-sequestering and mechano-transducer signaling layer, 
the DEJ modulates a remarkable number of cutaneous cellular processes involved 
in skin structure, function, regeneration, and resistance to trauma [33]. Comprised 
mainly of Type IV collagen and laminin, like other BMZs, DEJ complexity has been 
dissected at the molecular level to reveal a complex network of other collagens (VII, 
XVII and XVIII), 4 different isoforms of laminin (511, 521, 311 and 332), perlecan, 
nidogens, SPARC, fibrulins-1 and -2, dystroglycans, and integrins a3b1 and a6b4. 
All of these DEJ components are altered during aging and these changes correlate 
with age dependent increases in both DEJ thickness and stiffness [65].
Immediately beneath the DEJ, forming nipple-like structures projecting into the 
epidermal compartment and containing unique ECM, microvasculature, special-
ized fibroblasts, and dermal mesenchymal stem cells is the papillary dermis (PD). 
Here, undulating dermal protrusions interdigitate with epidermal rete ridges (pegs) 
to increase surface area for nutrient transfer, trafficking of immune cells, and 
increased tensile strength. The transition of superficial to reticular dermis is static 
and defined mostly by changes in ECM structure but dynamic during repair and 
disease. The majority of space in reticular dermis is occupied by thick bundles of 
interstitial collagens I and III, elastin and fibrillin fibers, and amorphous ‘ground 
substance’ comprised of hyaluronic acid, proteoglycans and glycoproteins. Like the 
DEJ, most if not all these dermal ECM components are altered and/or dysfunctional 
due to aging [35]. Both intrinsic and extrinsic aging correlate with the loss of rete 
ridges and flattening of dermal papillae [29, 30]. Compared to young, non-exposed 
and old photo-protected skin, the PD of chronically photodamaged skin displays 
marked structural changes, the most dramatic feature of which is the presence of 
“solar elastosis” in the superficial dermis. Solar elastosis consists of pathologically 
altered elastin fibrils [66] that present as dense accumulations of amorphous mate-
rial best visualized with trichrome staining.
The cellular composition of these dermal sub-compartments is a complex mix of 
fibroblasts, endothelial cells, myofibroblasts, macrophages, mast cells, trafficking 
immune cells, adipocytes, various stem cells, sensory neurites, and the differenti-
ated cellular components of dermal adnexa (including the hair follicle). An example 
of such cellular complexity, the significance of which continues to evolve, is the 
apparent postnatal plasticity of the dermal fibroblast. Single cell RNA sequencing 
has revealed at least four different subpopulations of human dermal fibroblasts  
[67, 68], and skin aging has been demonstrated to have a strong effect on both 
dermal ‘fibroblast’ phenotype and functionality. For example, young papillary 
dermal fibroblasts can direct reformation of youthful DEJ and epidermal structure 
and function, whereas old papillary and/or reticular dermal fibroblast populations 
cannot [69]. Furthermore, it is the senescent PD fibroblast and CD271+, laminin 
332-expressing interfollicular stem cells that contribute to age-associated pathologic 
remodeling of the DEJ [33, 70]. Recent attention has focused on specific dermal 
fibroblast subpopulations and their involvement in wound healing, fibrosis, and 
loss of epidermal stem cell ‘stemness’ due to niche signaling dysfunction. The 
homeobox gene engrailed-1 (EN-1) expression appears to distinguish two types of 
fibroblasts; those cells expressing EN-1 are associated with fibrotic healing pheno-
type whereas EN-1 negative fibroblasts promote physiologic remodeling [71, 72]. 
Epigenetic modulation of the fibrotic phenotype is reviewed in the next section.
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2.3 Subcutaneous layer involvement in skin aging dysfunction
The subcutaneous compartment (hypodermis) is composed mainly of cellular 
lipid storage units (adipocytes) separated by thin weblike networks of specialized 
ECM stroma containing microvasculature, adipose derived mesenchymal stem 
cells (ADSC) and immune cells. It functions as a thermoregulatory and shock-
resistant barrier, as well as a reservoir of bioactive factors involved in systemic lipid 
metabolism, energy balance, and endocrine function [73]. Subcutaneous fat also 
undergoes age-related changes that are generally like the epidermal and dermal 
compartments where an ‘atrophic’ phenotype becomes clinically evident. With 
aging, subcutaneous fat deposits in various body locations disappear and/or are 
redistributed to visceral locations elsewhere in the body, causing esthetic concerns; 
this redistribution is associated with a variety of systemic age-related disease states, 
including insulin resistance, metabolic syndrome, cardiovascular disease, and 
obesity [74, 75]. Of note, senescent cells have been shown to accumulate in aged 
adipose tissue [76], contributing to systemic inflammaging. Experimental clear-
ance of senescent cells can dramatically affect the redistribution of fat from the 
visceral to the subcutaneous compartment and decrease SASP expression [77]. The 
mechanism(s) of adipose cell senescence has not been clearly defined; however, 
ADSC exhaustion, oxidative stress by reactive oxygen species (ROS), and niche 
disruption appear to play important roles [78].
The influence of adipogenic hormones in skin aging and senescence has 
received recent attention with the discovery that UVB-light induced PS in human 
keratinocytes can be rescued by adiponectin via its suppression of inflammatory 
signaling pathways and human beta defensin-2 (hBD2) expression [79]. Human 
dermal fibroblasts express adipokine receptors and both leptin and adiponectin 
have been shown to stimulate expression of the ECM components hyaluronic acid 
and interstitial collagen [80]. These adipogenic hormones secreted by subcutaneous 
fat cells thus appear to represent paracrine cutaneous anti-aging factors for both the 
epidermal and dermal compartments.
‘Fat grafting’ has become a popular procedure in esthetic medicine and a variety 
of other clinical indications [81, 82] with special attention focused on ADSC. These 
cells can be isolated from subcutaneous fat removed during liposuction procedures 
after the stromal vascular fraction (SVF) is either mechanically sorted or enzymati-
cally digested with bacterial collagenase, decanted (or centrifuged), washed, and 
grafted [83]. SVF is composed of cellular components (pre-adipocytes, adipocytes, 
histiocytes, endothelial cell progenitor cells and ADSCs) and is a rich source of 
growth factors (i.e., bFGF, IGF-1, VEGFs, PDGF-BB), matrikines, and other para-
crine cellular factors. The ADSC secretome has been well characterized, consisting 
of soluble protein factors and lipid membrane particles (exosomes and ectosomes) 
that are used internationally in multiple therapeutic clinical trials for a vast array of 
indications, including dermatologic conditions (esthetics, wound healing, fibrotic 
diseases, dermatoporosis, etc). It is the loss of ADSC stemness, decreased prolifera-
tive potential, and dysfunctional secretome expression accompanying skin aging 
that continues to draw intense interest [82].
3. Genetic influences on cutaneous cellular senescence
The two major molecular pathways resulting in RS and PS have been observed 
in the skin [23]. These are reviewed in the following section by examining first the 
genetic aspects of cutaneous cellular senescence, followed by epigenetic influences. 
It should be noted here that acquisition of these cellular senescence phenotypes 
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plays a critical role in both normal organismal and tissue level physiology by, for 
example, dampening fibrotic responses during the remodeling phase of wound 
repair or suppressing tumor formation [84]. However, it also appears to be a major 
pathologic driver in age-related disease states [85].
3.1 DNA damage related to telomere biology
The senescent phenotype can be activated by DNA damage at the ends of all 
eukaryotic chromosomes, called telomeres, which consist of DNA loops containing 
noncoding repeats of guanine-rich sequences complexed with protective oligomeric 
proteins (Shelterins). Discovery that chromosomal replicative machinery respon-
sible for somatic cell division cannot synthesize exact duplicates of these structures 
led to the concept of the ‘end-replication problem’ during serial passaging [20]; 
thus, telomeric DNA is subjected to attrition because DNA polymerase fails to 
replicate the 3′ lagging strands.
Telomeric DNA are shortened by approximately 50–200 bp per cell division 
and thus a molecular clock is achieved, reflecting the replicative history of primary 
cells [86]. A specialized DNA polymerase (telomerase) is responsible for fixing 
the ‘end replication problem’, maintaining telomeric length, but its expression 
and function are restricted to immortal postnatal cells; in vivo, comprising stem, 
progenitor, and cancer cells. When cells reach their ‘Hayflick Limit’ telomeres lose 
enough DNA [87] to trigger a genomic instability signal and chromosomes become 
‘uncapped’ by loss of Shelterin. This genomic instability signal is a specialized DNA 
damage response (DDR) and generates telomere dysfunction-induced foci (TIFs). 
Approximately half of all persistent DNA damage foci are localized to telomeres, 
and these can trigger RS. But senescent cells can harbor many other forms of 
persistent chromosomal DNA damage foci, called DNA-SCARS (DNA segments 
with chromatin alterations reinforcing senescence) [9]. These dynamic structures 
can also trigger cell cycle arrest and SASP induction.
Independent of telomere length or uncapping by loss of Shelterins, guanine-rich 
telomeric DNA repeats can become damaged by ROS, generating DDR telomere-
associated foci (TAFs), which are associated with triggering the senescence 
phenotype [19]. This observation has particular relevance to the state of chronic 
inflammation, SASP expression, and tissue aging (Inflammaging) in skin and other 
tissues [15, 88, 89], as discussed in Section 3.2.
While epidermal, dermal, and subcutaneous cellular compartments all harbor 
evidence of RS in aged skin tissue, direct evidence that telomeric DNA associated RS 
is involved in skin aging is supported by experiments involving ectopic expression 
of human telomerase (hTERT). We reported that neonatal human dermal microvas-
cular endothelial cells (HDMEC) undergo RS in vitro but can become immortalized 
with viral transfer of the catalytic subunit of hTERT [90]. Furthermore, these 
telomerized HDMEC formed fully functional microvessels in vivo (perfused with 
murine blood) that exhibited superior durability with time after xenografting in 
immunodeficient mice versus vessels created with in vitro-aged primary HDMEC 
[91]. As previously reviewed, cutaneous microvasculature of aged papillary dermis is 
markedly reduced and abnormally structured versus young dermis [38], presenting 
clinically as telangiectasia and senile purpura/dermatoporosis. The roles of RS, OIS, 
and other senescent pathways on skin vasculature remain to be determined.
3.2 Genotoxic and exposome insults
As noted in the introduction, cellular senescence can be induced in the absence 
of any telomeric damage or loss and this premature senescence (PS) has similar 
Senescence
8
deleterious effects on aged tissues, including the skin. The triggers for the PS pro-
gram generally fall into (a) accumulation of subcytotoxic, unrepairable, non-telo-
meric DNA damage, including mitochondrial DNA (mtDNA), (b) macromolecular 
insults to cytosolic and secreted proteins and lipids, and (c) metabolic dysfunction 
involving an altered mitochondrial-lysosomal axis [92]. All of these PS triggers have 
been demonstrated in skin cells in vitro and in vivo [93].
The molecular and cellular effects of chronic UV light exposure (photoaging) have 
also been well-documented and, in many ways, more extensively than intrinsically 
aged human skin. Both UVA (320–400 nm, less energy) and UVB (280–320 nm, more 
energy) light cause photoaging but UVB is mostly absorbed by the epidermis, where it 
causes sunburns. UVA penetrates the superficial and reticular dermal compartments 
and is considered a major factor in photoaging. While both UVA and UVB wavelengths 
generate reactive oxygen species (ROS), indirectly damaging DNA, UVB is also 
directly mutagenic, causing DNA defects called cyclobutene pyrimidine dimers and 
6–4 photoproducts [94]. Remodeling of dermal ECM favoring an atrophic phenotype 
is triggered in unwounded skin by UV exposure via the activation of mitogen-acti-
vated protein kinase (MAPK) and activator protein 1 (AP-1) signaling pathways which 
causes downstream expression of matrix metalloproteinases (MMPs) in both the 
epidermal and dermal compartments [95]. These same pathways block transforming 
growth factor beta (TGF-β)/SMAD signaling via TGF-b type II receptor down regula-
tion causing decreased collagen synthesis [96, 97]. Dissection of the molecular effects 
of chronic UV exposure on the DEJ and PD have been recently reviewed [33].
Our understanding of the role senescent cells play in cutaneous aging patholo-
gies continues to evolve. In the past, senescent cells observed in the skin with 
biomarkers in vivo were believed to be passive, unresponsive bystanders recognized 
morphologically by their enlarged, seemingly flattened, abnormal shapes and 
senescence-associated (SA) β-galactosidase staining. But characterization of SASP 
expression in senescent cells (and their paracrine effects) provided compelling 
evidence that senescent cells are anything but passive.
It is now widely accepted that senescent cells remarkably influence surround-
ing non-senescent neighbors and ECM networks via secretion of inflammatory 
cytokines, chemokines, matrikines, MMPs, tissue inhibitors of metalloproteinases 
(TIMPs), and other proteinase-inhibitor systems that comprise the tissue ‘pro-
teinase web’ [98]. One such example is the role played by plasminogen activator 
inhibitor-1 (PAI-1) in modulating senescence. PAI-1 is a soluble and matrix bound 
serine protease inhibitor with multiple matricellular functions and can be found at 
increased levels in both dermal fibroblasts from aged donors and premature aging 
syndrome patients [99–101]. Ectopic expression of PAI-1 in fibroblasts induces the 
senescent phenotype and is both necessary and sufficient for RS downstream of p53 
[102]. Many other examples of SA ECM alterations have been reviewed [33].
The quintessential example of extrinsic aging involves the postmitotic dermal 
fibroblast population which responds to ‘expososomal’ damage [103] by activat-
ing DDR pathways, triggering PS and subsequent expression of macromolecular 
damage profiles involving mtDNA damage. One mechanism of mtDNA damage 
appears to involve UV light-induced deletion of a significant length of mtDNA, 
termed the ‘common deletion’ (CD) [104]. This 49 kb mtDNA fragment contains 
codons for electron transport chain (ETC) protein complexes I, IV and V which 
together express 72 ETC subunits, the loss of which cripples physiologic functions 
of mitochondrial energy metabolism, ROS protective mechanisms, and calcium 
homeostasis. Tracking the mtDNA CD in human skin revealed that both intrinsic 
(photo-protected) and extrinsic (chronic UV-damaged) skin contain this marker 
[105], and that dermal fibroblasts appear to be the culprit for subsequent age-
related tissue damage of ECM [106, 107].
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3.3 Genetic skin diseases associated with DNA repair pathway defects
Analysis of progeroid syndromes have provided insights into molecular 
mechanisms of intrinsic and extrinsic skin aging. Common skin phenotypic signs 
and symptoms shared by both these premature aging disorders and skin aging 
in the general population include skin atrophy, alopecia, fibrosis, telangiectasia, 
poikiloderma, canities and both NMSC and melanoma. Rare autosomal recessive 
patterns of different mutations in DNA repair genes group these heritable disorders 
into those involving; (1) multiple defects in nucleotide excision repair (NER) genes 
[e.g., DNA polymerase eta (POLH) among six others] coding for repair proteins in 
xeroderma pigmentosum (XP) [108], (2) transcription and transcription-coupled 
NER genes in Cockayne syndrome (CS) and (3) mutations in the gene family of 
RecQ helicases involved in DNA double strand break repair in Werner syndrome, 
Bloom syndrome, and Rothman-Thomson syndrome [109]. In the latter three disor-
ders, mitochondrial defects have been well documented and correlate with cellular 
senescence phenotypes [110, 111]. In XP-V null mouse models, loss of POLH leads 
to obesity and marked adipose tissue senescent phenotype expression [112].
3.4 SNPs and transcriptomics
Several genome-wide association studies (GWAS) and meta-analyses performed 
on young and old populations have identified single nucleotide polymorphisms 
(SNPs) in genes thought to be correlated with skin aging [113–118] or ‘perceived’ 
facial age’ [119]. These large cohort-based studies suggest specific allelic variants 
of pigmentation gene (MC1R), aryl hydrocarbon receptor gene (AHR), basonuclin 
2 gene (BCN2), type-1 collagen alpha-2 gene (Col1A2) or SNPs within or near the 
DIAPH2, KCND2 and EDEM1 loci all appear to correlate with both intrinsic and 
extrinsic skin aging phenotypes and/or youthful skin appearance.
Of all these identified genes and their allelic variants, the biology of MC1R gene 
has received perhaps the most recent attention due to its central role in modulating 
human (and murine) skin pigmentation systems, the clinical influence of which 
led to the categorization of Fitzpatrick Skin Phototypes. MC1R signaling is associ-
ated with both skin cancer and skin aging via its mixed role in UV induced PS in 
melanocytes and promotion of efficient DNA damage repair [120]. Genetic variants 
of MC1R (coding for G protein-coupled transmembrane melanocortin receptor-1 
on melanocytes) are strongly linked to increased risk of both NMSC and melanoma 
in both red and brown Caucasian phototype cohorts [121]. Meta-analysis of several 
GWAS studies demonstrated SNPs in or near MC1R (and SLC45A2 and IRF4) corre-
lated with different skin aging phenotypes using a skin surface topographic scoring 
system of solar elastosis [116] and the MC1R gene may also affect inflammaging via 
generation of ROS independent of its function in melanin production [122].
Gene expression studies of the skin aging phenotype have revealed several 
important observations about the complexities of distinguishing intrinsic from 
extrinsic mechanisms, as they appear to overlap in many important ways. In human 
skin, gene profiling and transcriptomic analyses [115, 123–128] have identified 
thousands of upregulated and downregulated genes in old vs. young and intrinsi-
cally aged vs. extrinsically aged (photoaged) skin. One transcriptomic study 
showed genes associated with mitigating oxidative stress, control of lipid synthe-
sis, and epidermal differentiation were all downregulated in both exposed and 
photo-protected skin, whereas, elastin expression was increased in exposed skin 
(consistent with formation of solar elastosis), and interstitial collagen expression 
decreased in sun protected skin (consistent with intrinsic aging) [127]. Similarly, 
confirming histologic studies, expression profiling of human aging that spanned 
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subjects between the ages of 24–70 years demonstrated younger-appearing skin 
upregulated expression of the LAMA5 gene (DEJ component) and epidermal cell-
cell adhesion complex (desmosomal) genes DSC3 and CDH1 [126].
Race, sex, and skin tone of subjects also all play a role in the genetic correlates of 
skin aging. The expression of some aging related genes was found to be sex-dependent 
in a Caucasian sample [129], and studies in a Han Chinese sample showed distinct 
genetic variants and phenotypes from that in a Caucasian population [118]. These dis-
crete expression patterns further highlight the complexity of cataloging aging mecha-
nisms in the skin and suggest that much more information would be required from a 
wider diversity of samples to understand any potential global age-related changes.
Altogether, genetic factors, including telomere DNA loss, genotoxic accumu-
lation of mutations in both genomic and mtDNA, DDR signaling, DNA repair 
dysfunction, and allelic variations in key cutaneous protective genes controlling 
pigmentation, inflammation, dermal, epidermal, and subcutaneous physiology 
all converge on our emerging understanding of the central role cellular senescence 
plays in skin aging. What follows is a review of how epigenetic factors also influence 
cellular senescence in cutaneous biology and the aging phenotype.
4. Epigenetic influences on cutaneous cellular senescence
Though the evolution to senescence is usually characterized as a genomically 
driven phenotype, its manifestation can be largely characterized as an epigenetically 
entrenched state. The baseline definition of a senescent cell is an otherwise mitotic 
cell that has entered permanent cell cycle arrest, but this also begets a broader 
shift in cell behavior and protein production. For these changes to be permanent 
they must be encoded in long-term gene expression tendencies, i.e., in the cellular 
epigenome. The epigenome is the composite architecture consisting of chemical 
and physical modifications to the DNA that do not alter the underlying coding and 
noncoding sequences but instead modify its oligomeric structure and transcription. 
These modifications span multiple layers from the local control of specific gene 
promoters to large scale regulation of entire domains of genes.
Canonically, the epigenome is most strongly associated with cell identity, as it 
makes accessible the portions of genomic DNA needed for the cell’s functional role 
while segregating and silencing irrelevant regions. Thus, the most dramatic epigen-
etic shifts are observed when cells differentiate from stem or progenitor states. In 
this full and dramatic state transition, the function of the cell is redefined, affecting 
everything from its morphology to its protein production and factor secretion [130]. 
For skin this can mean, for instance, a transiently amplifying cell in the basal epi-
dermis fully differentiating to a corneocyte through natural turnover or endothelial 
progenitor cells differentiating into new endothelium in response to an angiogenic 
signal. Conversely, cells undergo constant but more minor epigenetic events as they 
are exposed to regular stimuli from the environment, which can lead to upregulation 
or downregulation of certain behaviors [131]. For instance, methylation sequenc-
ing of the same cell type across patients (e.g., epidermal keratinocytes) will show 
a distribution with perturbation on the mean population value based on internal 
and local external stimuli [132]. This heterogeneity evolves with different stressors, 
and with aging itself becomes more prominent. Eventually the stressors can lead to 
enough diversity to characterize pseudostates and pseudostate transitions that may 
by-and-large retain the cell’s identity but with a different grade of functionality across 
multiple genes. We will discuss a few additional examples of this in the following sec-
tions, like fibrotic versions of connective tissue cells and pro-/anti-inflammatory ver-
sions of macrophages; however, the focus of this section that could also be considered 
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an epigenetic pseudostate is senescence. It meets the criteria in that it still retains 
core cell identity but also dramatically affects a multitude of genes to alter protein 
production and secretion profile, and thus requires a core epigenetic component. In 
this section we will review the multitude of epigenetic changes that accompanies this 
pseudostate evolution in skin cells, what role they play in establishing the senescent 
phenotype and how they may potentially be engaged therapeutically.
4.1 Sequence specific modulation
One modality of epigenetic is sequence specific meaning it targets specific 
regions of the genetic code—either DNA or RNA. DNA base pair methylation is a 
well-known example of this modality. Cytosine is the most commonly methylated 
base in eukaryotic cells and when methylated, often serves to block the activity of 
RNA polymerase, as in the context of CpG islands. Found in the promoter region of 
many genes, CpG islands are clusters of methylated cytosine followed by guanine, 
wherein the methylation inhibits (silences) the transcription of that gene [132]. 
Widespread hypomethylation has been documented in aging and senescent fibro-
blasts, and in some cases, impairs cell cycling pathways through the suppression of 
cyclin pathways. Specifically, a lack of methylated sites leads to the upregulation of 
p16INK4a which inhibits cyclin D/CDK4 to suppress G1 phase progression, while 
upregulation of p14ARF leads to activation of p53/p21 and inhibits cyclin E/CDK4 
to prevent S phase progression [7]. The global methylation status of fibroblasts is 
directly and strongly correlated with donor chronological age through regression 
algorithms known as ‘epigenetic clocks.’ These algorithms calculate a weighted linear 
combination of the beta coefficients (the percent signal from the methylated out of 
the total unmethylated and methylated alleles) [133]. When dermal fibroblasts were 
passaged towards replicative senescence (RS) these epigenetic clocks show aggre-
gated methylomic evolution. The cell cycle was reengaged by overexpressing the 
telomerase gene hTERT, causing cells to progress to further doubling. However, the 
epigenetic clock did not reverse and the cells continued to age, bypassing RS, further 
hinting that a broader epigenetic change was occurring through the progression to 
senescence rather than just the suppression of a few mitotic arrest genes [134].
Conversely, sequence specific epigenetic regulation on the level of transcribed 
RNA is accomplished through feedback mechanisms by families of non-coding RNA-
including microRNAs, siRNAs, long and short non-coding RNAs, and others. These 
non-coding RNAs will interact with other DNA, RNA, and proteins to regulate their 
expression, further enhancing the complexity of the transcriptome over the more 
rigid landscape of the methylome [135]. Thus, non-coding species are often used to 
not just reinforce but also propagate the senescence response. The particular influ-
ence of miRNAs, short sequences that complement and bind to specific regions of 
mRNAs to limit their stability and thus their translation likelihood, has been explored 
in the context of cutaneous cell senescence [136]. For instance, UV-induced senescent 
fibroblasts are known to produce miR-34 which targets a number of transcripts 
within these cells for cell cycle regulatory genes like MYC and BCL2 as well as genes 
for other epigenetic factors such as E2H and SIRT1 [137]. Meanwhile, in wounding-
induced senescence the extracellular secretion of miR-21 as part of the SASP pheno-
type triggers the activation of resident macrophages to drive the local inflammatory 
response [138], but these represent only a few of a handful of drivers. Senescent 
keratinocytes, for instance, have displayed upregulation of over a hundred different 
microRNAs correlated with expression of the senescence biomarkers p16, p53, and 
senescence-associated β-galactosidase (SA-β-Gal) [136]. Together, these mechanisms 
represent the precise regulation of specific genomic targets and interfering with 




For regulation across gene domains (~150 base pairs or greater), the epigenome 
uses methods of physical compaction to close off regions of the genome from tran-
scription. The negative charge of the DNA attracts it to wrap around the positively 
charged protein octamer spools called histones, which segregate the sequences away 
from transcription machinery. Chemical modifications like methylation, acetyla-
tion, and ubiquitination of the amino acid residues on the tails of these histone 
proteins alter the charge interaction with DNA and with other histones influencing 
oligomeric structure [139]. Senescence engages in this mechanism by modulating 
the enzymatic activity that regulates these histone tails. For example, the activity of 
methyltransferases like EZH2, which adds trimethylation to the lysine residue 27 of 
histone 3 (H2K27me3), is reduced in senescent cells. This reduction in the resulting 
H3K27me3, especially at the INK4a/ARF locus mentioned previously, reinforces 
the discontinuation of the cell cycle [8]. Other forms of histone tail modification 
include acetylation, which tends to promote more transcription. One of the most 
well-studied classes of deacetylation enzymes is the sirtuin family of proteins. In 
both fibroblasts and keratinocytes, Sirt1 and Sirt6 directly respond to DNA dam-
age and inflammation, but their expression is diminished in senescent cells [140]. 
Interestingly, both Sirt1 and Sirt6 also play an active role in regulating collagen 
balance, thus their downregulation could be conceptually likened to senescence of 
the dermal ECM and its turnover, just like that of cellular turnover.
Histones can also be modified through changes within the core octamer proteins 
themselves and a hallmark example of this phenomenon is the variant species of the 
H2A protein known as H2A.J. This modified protein is prevalent in a lot of senescent 
skin cell types where it weakens the binding of another histone in the complex, H1, 
triggering a signaling cascade that preempts the interferon response and contributes to 
initiation of SASP expression [141]. In senescent epidermal keratinocytes in particular, 
the increase in H2A.J variants is correlated with arrested cell cycle and maturation of 
the basal cells into mature corneocytes, thus it may play a direct role in the morpho-
logic phenomena of epidermal thinning seen with age [142]. The broader contribution 
of these histone changes, along with local DNA methylation shifts, is the transition to 
wide-reaching genome compaction in senescent cells, for example the condensation 
of senescence associated heterochromatin foci, as in H3K9me3 rich regions of nuclease 
resistant compact facultative heterochromatin [11]. These foci are seen across skin cell 
types like fibroblasts and keratinocytes and are thought to entrench the senescent state 
by long term segregation and silencing of mitotic genes [143]. However, the evolution 
of these foci seems to be specific to the type of senescence induction, most prominent 
in OIS, suggesting that senescence itself may even be a family of pseudo-states rather 
than a distinct, singular manifestation [144]. Nevertheless, in general, these forms of 
epigenetic modification which bias entire regions of genes from active to passive and 
vice versa truly embody a cell state/pseudostate.
4.3 Alternative epigenetic pseudostates
The natural and prevalent engagement of senescence, even in young tissues, 
reflects its role as a form of stress response. In fact, a major function of senescence is 
to prevent the evolution of alternate, more detrimental states of the cells and tissue 
under these conditions. One such competing epigenetic pseudostate is fibrosis. The 
fibrotic transition is a common feature in the pathological evolution of many tissues, 
i.e., hypertrophic scarring and keloids in the skin, idiopathic pulmonary fibrosis in 
the lung, cirrhosis in the liver [145]. A key component of fibrosis is the differentia-
tion of various cell types including fibroblasts, adipocytes, epithelial cells, and 
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endothelial cells into a population known as myofibroblasts [146]. As mentioned, 
differentiation is canonically an epigenetic event as cells convert and specify their 
functional gene regions while silencing other unused regions. It involves the same 
modalities of control—methylation, histone tags, chromatin structure, etc.—often 
with more dramatic and permanent modifications. These activated myofibroblasts 
are critical for the repair response in that they secrete superfluous extracellular 
matrix (ECM) components (Collagen 1, alpha-smooth muscle actin (α-SMA), 
fibronectin, etc) that accumulate in the connective tissue [147]. At the same time, 
these cells diminish the process of anabolic degradation of ECM through reduction 
of MMPs [148]. Unbridled overgrowth of these myofibroblasts, as evidenced by the 
overactivation of growth factors like connective tissue growth factor (CTGF), leads 
to the buildup and disorganization of the connective tissue [149]. Senescence in this 
context is thought to be a responsive, secondary epigenetic evolution that is engaged 
to shut down this population and stop the overgrowth [150]. These processes—from 
the epigenetic cell identity shift (e.g., epithelial-to-mesenchymal or fibroblast-to-
myofibroblast transitions, depending on the starting cell types) to the epigenetic 
proliferation-suppressed state (induction of senescence)—represent relatively fast 
epigenetic turnovers. As such, a key mediator of this rapid transition is thought to 
be the slew of non-coding RNAs, like let-7 g to engage TGFbeta driven myoblast 
conversion and miR-127-3p to induce p53/p21 drivers of senescence [151, 152].
Another alternative pseudostate that competes with senescence is of course 
cancer and more particularly for skin, melanoma. Like senescence, cancer is a state 
transition that involves bypassing apoptotic pathways, yet these aberrant cells also 
bypass the suppression of their cell cycle gene networks [14]. It is thought that mel-
anoma cells are able to undo the senescence epigenetics and re-engage the cell cycle 
due to the deleterious recruitment of epigenetic enzymes, like histone demethylases 
and Jumonji proteins [153]. This means a host of pathways whose methylation 
would otherwise lead to cell cycle suppression, like the p15INK4B or the p27Kip1 
pathways, are methylated without cell cycle arrest in melanoma [154–156]. The use 
of inhibitors to target these epigenetic enzymes seems to be a promising methodol-
ogy to restore the cell cycle arrest and control the cancerous growth [157].
An interesting intersection of epigenetic and oncogenic pseudostates is high-
lighted in Merkel cell carcinoma (MCC). This aggressive, non-melanoma skin can-
cer is rare but occurs primarily in the elderly and immunosuppressed. Interestingly, 
methylation clock analysis of MCC cells shows their epigenetic age as significantly 
younger than the chronologic age of the patients from which they were derived—a 
stark contrast from the continually progressing epigenetic age of senescent cells. 
Further analysis of these MCC cells did not indicate any signs of pluripotency [64]. 
The mechanism by which MCCs reverse their epigenetic age is still unknown, how-
ever, it may be related to other epigenetic alterations recently discovered in this cell 
type, including decreased H3K27me3 expression [158, 159] and overactivity of the 
lysine-specific histone demethylase 1A [160, 161]. These are just some examples of 
this fundamental need to tightly control and disengage mitotic networks and why 
senescence requires a complex regulatory architecture like the epigenome.
4.4 Enablers of senescence
The phenomenon of senescence is promoted by the epigenetics of not just the 
arrested cells in question, but also that of the other resident cells that enable this 
transition. Though senescence is thought to be a permanent state, the persistence of 
senescence in the tissue is only meant to be transient. This is because the key func-
tion of this state is to respond to stressors by retaining cells, despite their damage, 
to maintain the tissue temporarily while preventing them going down the more 
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detrimental alternate routes mentioned, all the while signaling the immune system 
and other repair mechanisms. When the immune system is young and efficient 
its cells are recruited to the skin and other tissues to clear out the senescent cells 
[162]. With aging, however, the number and lifetime of these senescent populations 
increases due to the altered epigenetic pseudostates of the senescent clearing cells 
as well, contributing to innate immunosurveillance dysfunction of the skin. One 
example of this is in the dominance of the pro-inflammatory M1 macrophage pseu-
dostate over the anti-inflammatory M2 macrophage pseudostate [163]. There are a 
number of histone methylation and acetylation modifiers that play a role in pseu-
dostate fate decision, for instance histone deacetylase 3 promoting M1 macrophages 
or the SYMD family of methyltransferases promoting M2 macrophages [164]. With 
the accumulation of stressors over a lifetime, the more pro-inflammatory epigenetic 
pseudo-states are favored in skin and other tissues, especially in response to fac-
tors like SASP or inflammaging [165]. In addition, in some disease states like type 
2 diabetes, the wound healing response and inflammation tends to exaggerate the 
M1 state response with focal DNA methylation components at sites like peroxisome 
proliferator activated receptor gamma (PPARγ) or and elevation of miR-125b [164]. 
This epigenetic shift in the balance of macrophage cells then ties back to senescence 
as the M1 macrophage predominantly engages in more phagocytic clearance of 
foreign pathogens, while the M2 macrophages carry out more phagocytic clear-
ance of damaged host cells (efferocytosis) [166]. This, coupled with the fact that 
senescent cells develop ways to better evade apoptosis, means that they are more 
likely to accumulate [167] in aged tissue. There are additional immune cell types 
that are similarly driven by the pro-inflammatory transition, yet become impaired 
at senescent cell clearance, including NK cells and neutrophils [167]. Altogether, 
this epigenetic evolution of the regulator cells, part of inflammaging, proves just as 
critical to the manifestation of a sustained senescence pressure in cutaneous tissue 
as epigenetic changes engaged in the non-dividing cells themselves.
4.4.1 Distinction from temporary cell cycle arrest
Though sometimes associated with senescence, somatic stem cells (as opposed to 
differentiated cells) are typically associated with another form of cell cycle arrest, 
known as quiescence. Because their role is to remain as a niched tissue reserve, they 
often enter periods of temporary cell cycle arrest with a prolonged G0, instead of 
a permanent one, until they are called to activate, to proliferate and differentiate, 
by a stressor [168]. One major epigenetic distinction that enables this temporary 
quiescence vs. permanent senescence is the utilization of bivalent domains. These 
are regions of genes that are regulated by both a repressive histone tag as well as an 
activating one, that allows the region to rapidly switch from one state to another 
depending on stimulus [169]. A prime example of the use of this is in the coincid-
ing utilization of repressive H3K27me3 and activating H3K4me3, which maintains 
a tenuous baseline suppression of the gene region. This pair forming a bivalent 
domain is widely used throughout the embryonic stem cell genome, establishing its 
broad potency as a cell type with the potential to express a lot of different proteins 
[170]. But when the same domains were searched for in dermal hair follicle stem 
cells (HFSC), they were found to be substantially restricted to lineage-specific 
factors like Sox9 and Nfatc1 and growth factor FGF18 [171]. Then, when these HFSC 
were stimulated to activate, many of the genes with H3K4me3 activating markers, 
which are located primarily near the gene promoters, were further reinforced by 
additional H3K79 dimethylation in the gene body, to tip the scale from suppression 
to activation [171]. These genes included many cell cycle regulators which, when 
combined with the cell lineage factors, properly executed differentiation. Thus, 
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this mechanism of readily switchable suppression to expression establishes a major 
distinction in epigenetic regulation from cell cycle in quiescence from that of senes-
cence where the cell cycle genes are more permanently, epigenetically suppressed.
4.4.2 Manipulability of senescent epigenetics
Earlier, we mentioned how drugs targeting epigenetic enzymes represent one 
methodology for modulating some of the epigenetic changes that drive senescence, 
such as senolytic therapies. However, a broader and more dramatic approach of 
epigenetic evolution is through the process of cellular reprogramming. This tech-
nology was inspired by the core epigenetic reset that occurs during the process of 
reproduction in which sperm and egg, two cells with very precise roles and epigen-
etic identities, are reprogrammed to make embryonic cells—epigenetically plastic 
cells that can differentiate into any cell in the body. The isolation and recapitulation 
of this process in any desired cell type was achieved through the discovery of core 
transcription factors [172]. When overexpressed in cells, this set of core transcrip-
tion factors would drive a full epigenetic remodeling to produce embryonic-like cells 
with all their differentiation potential. This process is called induced pluripotent 
stem cell reprogramming (iPSC) and has been utilized in a variety of different cell 
types with dermal fibroblasts being the gold standard for many studies [173]. Even 
fully senescent fibroblast populations established from 51 population doublings and 
maintained for two months in culture, successfully showed iPSC reprogramming, as 
evidenced by revived proliferation, reduced p16 and p21, and re-differentiation after 
reaching the pluripotent state [174]. Crucially, the re-differentiated progeny were 
once again able to be passaged into senescence, thus suggesting that malignant trans-
formation was not induced during the entire process. Furthermore, one of the key 
reprogramming factors Oct4, has been shown to independently re-engage senescent 
hair follicle mesenchymal stem cells back into cycling by engaging a host of DNA 
methyltransferase to inhibit the p21 pathway [175]. More recently researchers have 
shown that the prevalence of senescence in a population can be reduced with even 
a transient application of the reprogramming factors [176–178]. Though whether 
this means a re-engagement of senescent cells in the cell cycle or simply competitive 
growth advantage of healthy cells remains to be seen. This represents an enticing 
new possibility in that epigenetic manipulation may possibly counter the accumula-
tion of senescent cells in many aged and diseased tissues, including the skin.
5. Conclusion
The skin represents an excellent organ system in which the effects of cellular 
senescence manifest as observed clinical changes in organismal health and disease. 
A myriad of processes drives the genomic erosion that instigates the transition to 
senescence. Some of these processes are more stereotyped, engineered into the cell 
by design, and are observed in chronologically aged skin, while others are stochas-
tic and driven by environmental conditions, exemplified by exposomal damage. 
Either way, the result is an evolution of the entire state of the cell. This means more 
than just the direct arrestation of the cell cycle, but also entails changes through 
the cellular transcriptome, proteome, and secretome as encoded by alterations to 
the core cellular epigenome. This also involves a myriad of changes to the many 
layers of architecture that encode a cell’s function and identity. The global process 
is critical for the skin’s ability to retain functional integrity upon stress and insult as 
the first line of defense for the body, and in many ways, senescence represents the 
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This review gives a glimpse of how and why intrinsic and extrinsic factors 
trigger cutaneous cellular senescent phenotypes, leaving several important ques-
tions unanswered. For example, which genetic and epigenetic factors determine the 
dominant decision pathways favoring senescence vs. apoptosis or any other disease 
states for different skin compartments? How are the various types of senescence 
manifestations comparable in terms of evolution and manipulability? What are the 
molecular and cellular consequences of therapeutic re-engagement of senescent 
cells into the cell cycle? As the focus on aging grows as an ever more prominent 
factor in clinical and investigative dermatology, insights on these questions into the 
nature of senescence become a critical step towards both dermatologic therapeutic 
advancement specifically and translational medicine in general.
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